High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234.
Vogelzang NJ, Herndon JE 2nd, Miller A, Strauss G, Clamon G, Stewart FM, Aisner J, Lyss A, Cooper MR, Suzuki Y, Green MR.
Vogelzang NJ, et al.
Ann Oncol. 1999 May;10(5):597-600. doi: 10.1023/a:1026438215309.
Ann Oncol. 1999.
PMID: 10416012
Free article.
Clinical Trial.